The clinical and pathological characteristics of Chinese patients with pauci-immune crescent glomerulonephritis

Chinese Medical Journal

Volumn 114, Issue 4, 2001, Pages 374-378

  Tang, Zheng ^a   Yao, Xiaodan ^a   Hu, Weixin ^a   Zeng, Caihong ^a   Chen, Huiping ^a   Liu, Zhihong ^a   Li, Leishi ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Anti neutrophil cytoplasmic antibody; Clinico pathology; Pauci immune crescent glomerulonephritis

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHILD; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED;

EID: 0039146176     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Couser WG. Rapidly progressive glomerulonephritis: classification, pathogenic mechanisms, and therapy. Am J Kidney Dis 1988;11:449-464.
2. Glassock RJ. Primary glomerular disease. In: Kidney (I) . Philadelphia: Saunders; 1986:929-932.
3. Aandrassy K, Kuster S, Waldberr R. Rapidlly progressive glomerulo-nephritis: analysis of prevalence and clinical course. Nephron 1991;59:206-213.
4. Zent R, Van Zyl Smit R, Cassidy MJD. Crescentic nephritis at Groote Schuur Hospital, South Africa-not a benign disease. Clin Nephrol 1994; 42:22-29.
5. Zeng CH, Tang Z, Chen HP, et al. The analysis of diffuse crescentic glomerulonephritis in 72 patients. J Nephrol Dial Transplant 1996;5:10-14.
6. Austin HA, Muenz LR, Joyce KM, et al. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcomes. Kidney Int 1984;25:689-695.
7. Tang Z, Zhou H, Yao XD, et al. Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis. Chin Med J 1997; 110:206-209.
8. Tang Z, Li SH, Zhang JH, et al. Pulse methylprednisolone and monthly intravenous ryclophosphamide therapy in patients with severe glomerulonephritis. Bull Jinling Hosp 1992;5:197-201.
9. Zhang SL, Li LS. The detection and significance of anti-myeloperoxidase ( MPO) antibodies in patients with polyarteritis nodosa. Chin J Nephrol 1995; 11: 197-200.
10. Zhang SL, Li LS. The detection of anti-MPO antibody by ELISA. Shanghai J Immunol 1995; 15:81-85.
11. Tang Z, Li LS, Chen HP, et al. Clinic and pathology of diffuse crescentic glomerulonephritis. Chin J Nephrol 1993;9:273-277.
12. Falk RJ, Hogan S, Carey TS, et al. The glomerular disease collaborative network. Clinical course of anti-neutrophial cytoplasmic autoantibody-associate glomerulonephritis and systemic vasculitis. Ann Intern Med 1990;113:656-663.
13. Pettersson EE, Sundelin S, Heigl Z. Incidence and outcome of pauci-immune necrotizing and crescentic glomerulonephritis in adults. Clin Nephrol 1994;43:141-149.
14. Johnson RJ. The mystery of anti-neutrophial cytoplasmic autoantibodies. Am J Kidney Dis 1995;26:57-61.
15. Bolton WK, Innes DJ, Sturgill BC, et al. T-cells and macrophages in rapidly progressive glomerulonephritis: clinico-pathologic correlations. Kidney Int 1987;32:869-876.
16. Huang XR, Holdsworth SR, Tipping PG. Evidence for delayed-type hypersensitivity mechanisms in glomerular crescentic formation. Kidney Int 1994;46:69-77.